<div class="headers"><div>FIGURE 1 Forest plot of baseline factor effect on annual exacerbation rate ratio with benralizumab every 8 weeks (Q8W, first three doses every 4 weeks) and high-dosage inhaled corticosteroid (ICS) plus long-acting β2-agonist (LABA) for the overall population (full analysis set (FAS), pooled). OCS: oral corticosteroid; BD: bronchodilator; FVC: forced vital capacity. Data are from the pooled intention-to-treat population from the high-dosage ICS/LABA treatment cohorts of the SIROCCO and CALIMA studies. Estimates were reweighted to account for the 2:1 stratification for baseline blood eosinophil counts (⩾300 and <300 cells·μL−1). Estimates were calculated by using a negative binomial model with adjustment for study code, region, OCS use at time of randomisation where applicable, prior year exacerbations and treatment. The log of each patient’s corresponding follow-up time was used as an offset variable in the model to adjust for different exposure times during which the events occurred.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<tbody>
<tr style='border-top: 2px solid grey;'>
<td style='border-top: 2px solid grey; text-align: left;'><p style="" class="">Subgroup name/level</p></td>
<td style='border-top: 2px solid grey; text-align: left;'><p style="padding-left:20px; " class="indent1 ">Estimate (95% Cl)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">FAS</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.66 (0.55-0.75)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">OCS</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.62 (0.29-0.60)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">No OCS</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.69 (0.58-0.82)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Nasal polyps</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.50 (0.35-0.72)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">No nasal polyps</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.68(0.57-0.81)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Pre-BD FVC <65% of predicted</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.53(0.39-0.71)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Pre-BD FVC s65% of predicted</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.69 (0.58-0.83)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">s3 exacerbations</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.56 (0.63-0.67)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">2 exacerbations</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.76 (0.60-0.90)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Age at diagnosis s18 years</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.59 (0.69-0.71)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Age at diagnosis <18 years</p></td>
<td style='text-align: left;'><p style="" class="">1    0.79(0.61 1.02)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">Either OCS use, nasal polyps, pre-BD FVC <65% of predicted or age at diagnosis sl8 years</p></td>
<td style='text-align: left;'><p style="padding-left:20px; " class="indent1 ">0.60 (0.51-0.71)</p></td>
</tr>
<tr>
<td style='text-align: left;'><p style="" class="">No OCS use, no nasal polyps, pre-BD FVC s65% of predicted and age at diagnosis <18 years</p></td>
<td style='text-align: left;'><p style="" class="">-1    0.86(0.59-1.25)</p></td>
</tr>
<tr>
<td style='text-align: left;'></td>
<td style='text-align: left;'></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'></td>
<td style='border-bottom: 2px solid grey; text-align: left;'></td>
</tr>
</tbody>
</table>
